Patents Assigned to Takara
  • Patent number: 12207666
    Abstract: Provided is a green tea-containing beverage including: (A) green tea; (B) at least one selected from the group consisting of phytic acid, tartaric acid, and gluconic acid; and (C) at least one selected from the group consisting of ascorbic acid, a salt of ascorbic acid, erythorbic acid, and a salt of erythorbic acid, wherein the green tea-containing beverage has a copper content of 0.3 mg/L or more. Preferably, the concentration of the constituent (B) is 0.05-2.5 g/L. Preferably, the concentration of the constituent (C) is 0.2-5 g/L. Preferably the green tea-containing beverage further includes alcohol. Also provided is a method for preventing discoloration of a green tea-containing beverage, the method including: incorporating the constituents (B) and (C) in the green tea-containing beverage; and further incorporating copper so as to give the copper content of 0.3 mg/L or more.
    Type: Grant
    Filed: September 17, 2019
    Date of Patent: January 28, 2025
    Assignee: TAKARA SHUZO CO., LTD.
    Inventors: Momoko Matsuyama, Manabu Osaki
  • Patent number: 12203128
    Abstract: Provided are methods of producing product nucleic acids involving the use of oligonucleotides that are modified by the application of a stimulus. Aspects of such methods may include producing product nucleic acids using de-activatable oligonucleotides that are deactivated by a de-activating stimulus, as well as methods that may include producing product nucleic acids using activatable oligonucleotides that are activated by an activating stimulus and de-activatable oligonucleotides that are deactivated by a de-activating stimulus. Also provided are kits, compositions and devices that include de-activatable oligonucleotides or activatable and de-activatable oligonucleotides, e.g., for use in performing the methods as described herein.
    Type: Grant
    Filed: April 24, 2023
    Date of Patent: January 21, 2025
    Assignee: Takara Bio USA, Inc.
    Inventor: Kazuo Tori
  • Publication number: 20240309341
    Abstract: Provided are: a DNA polymerase mutant having reverse transcriptase activity, the DNA polymerase mutant including a sequence consisting of twelve specific amino acids A1-A12, wherein the DNA polymerase mutant having reverse transcriptase activity is characterized in that the A3 and/or A10 amino acid is substituted by a basic amino acid residue different from that prior to the introduction of mutation; a kit and a composition including the DNA polymerase; a method for producing the DNA polymerase; and a method for modifying an existing DNA polymerase having reverse transcriptase activity.
    Type: Application
    Filed: May 10, 2024
    Publication date: September 19, 2024
    Applicant: Takara Bio Inc.
    Inventors: Takashi UEMORI, Hiroyuki Matsumoto, Kensuke Saito, Miwa Akitomo
  • Patent number: 12070427
    Abstract: A moving unit includes a housing, a rotary unit to which a rod part is attached, a spring that generates a torque when the rod part is tilted down or tilted up about a rotation axis on the side on which a base portion of the rod part is located, and a torque adjustment unit that is capable of adjusting a torque by deforming the spring. The torque adjustment unit includes a spring deforming portion that deforms the spring in a direction in which the spring is wound up and a spring fixing portion that keeps a torque constant by coming into contact with the spring deforming portion and fixing the spring deforming portion in place.
    Type: Grant
    Filed: November 17, 2017
    Date of Patent: August 27, 2024
    Assignee: Takara Belmont Corporation
    Inventors: Koji Nakajima, Hiroyuki Terayama
  • Patent number: 12065644
    Abstract: Methods of preparing nucleic acid libraries are provided. Aspects of the methods include producing one or more libraries, including e.g., expression libraries and/or immune cell receptor repertoire libraries, from double stranded complementary DNA (cDNA) generated through a template-switching reaction involving a RNA sample. In some aspects, the methods include preparing a library from a single cell and/or a library indexed at the single cell level. Compositions and kits for use in performing the methods are also provided.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: August 20, 2024
    Assignee: Takara Bio USA, Inc.
    Inventors: Magnolia Bostick, Ishminder Mann, Andrew Alan Farmer, Sarah Taylor
  • Patent number: 12018276
    Abstract: In the present invention, lymphocytes are efficiently grown by culturing lymphocytes in the presence of a novel recombinant fibronectin fragment.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: June 25, 2024
    Assignee: TAKARA BIO INC.
    Inventors: Tomomi Otsuji, Yuka Hirase, Asako Hatsuyama, Sachiko Okamoto, Tatsuji Enoki, Junichi Mineno
  • Patent number: 12018294
    Abstract: Provided are: a DNA polymerase mutant having reverse transcriptase activity, the DNA polymerase mutant including a sequence consisting of twelve specific amino acids A1-A12, wherein the DNA polymerase mutant having reverse transcriptase activity is characterized in that the A3 and/or A10 amino acid is substituted by a basic amino acid residue different from that prior to the introduction of mutation; a kit and a composition including the DNA polymerase; a method for producing the DNA polymerase; and a method for modifying an existing DNA polymerase having reverse transcriptase activity.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: June 25, 2024
    Assignee: TAKARA BIO INC.
    Inventors: Takashi Uemori, Hiroyuki Matsumoto, Kensuke Saito, Miwa Akitomo
  • Patent number: 11999972
    Abstract: Stem cells can be efficiently proliferated by culturing the stem cells in the presence of a novel recombinant fibronectin fragment.
    Type: Grant
    Filed: July 28, 2017
    Date of Patent: June 4, 2024
    Assignee: TAKARA BIO INC.
    Inventors: Tomomi Otsuji, Toshikazu Nishie, Risa Kato, Sachiko Okamoto, Tatsuji Enoki, Junichi Mineno
  • Patent number: 11959078
    Abstract: Methods of preparing a next generation sequencing (NGS) library from a ribonucleic acid (RNA) sample are provided. Aspects of the methods include combining the RNA sample with a first strand cDNA primer and a template switch oligonucleotide under first strand cDNA synthesis conditions, where one of the first strand cDNA primer and the template switch oligonucleotide includes a first post-tagmentation amplification primer binding domain. The resultant product is subjected to amplification conditions sufficient to produce a double stranded cDNA, which is then tagmented with a transposome that includes a second post-tagmentation amplification primer binding domain. The tagmented sample is then subjected to amplification conditions using first and second post-tagmentation amplification primers that include sequencing platform adapter constructs to produce a NGS library. Aspects of the invention further include compositions produced by the methods and kits that find use in practicing the methods.
    Type: Grant
    Filed: October 21, 2020
    Date of Patent: April 16, 2024
    Assignee: Takara Bio USA, Inc.
    Inventors: Cynthia Chang, Magnolia Bostick
  • Patent number: 11884963
    Abstract: Provided are methods of depleting a target nucleic acid from an initial collection of nucleic acids. Aspects of the methods include contacting the initial collection with a nucleic acid guided nuclease specific for the target nucleic acid in a manner sufficient to deplete the target nucleic acid from the initial collection. Depending on a given application, depletion of a target nucleic acid may vary, e.g., where depleting may include cleaving a target nucleic acid in, or selectively separating a target nucleic acid from, the initial collection of nucleic acids. Also provided are compositions and kits for practicing embodiments of the methods.
    Type: Grant
    Filed: April 20, 2021
    Date of Patent: January 30, 2024
    Assignee: Takara Bio USA, Inc.
    Inventors: Andrew Alan Farmer, Craig Betts, Nathalie Bolduc
  • Publication number: 20230330214
    Abstract: Provided is DNA that: encodes a coronavirus (SARS CoV-2) spike protein or a fragment thereof; and has been optimized to partially or fully exhibit a codon included in a DNA sequence.
    Type: Application
    Filed: September 30, 2021
    Publication date: October 19, 2023
    Applicants: OSAKA UNIVERSITY, TAKARA BIO INC., ANGES, INC.
    Inventors: Hironori NAKAGAMI, Ryuichi MORISHITA, Hiroki HAYASHI, Yasunori AMAISHI, Sachiko OKAMOTO, Junichi MINENO, Hisato IKAI, Junko MICHIBATA, Takao KOMATSUNO
  • Publication number: 20230270532
    Abstract: Provided is an instrument holder that allows an instrument to be smoothly, safely, and hygienically handled by holding the instrument in a standing posture when in use and by holding the instrument in a posture not allowing the instrument to easily contact a practitioner when not in use. A holder portion 15 of an instrument holder 12 has a pair of supporting body portions 16, a rotational body portion 23 that is supported by the supporting body portions 16 and that is rotatable, and a holder body portion 31 that is attached to the rotational body portion 23. The holder portion 15 alternately changes between a rearwardly tilting holding state and a forwardly tilting waiting state due to rotation of the rotational body portion 23.
    Type: Application
    Filed: July 19, 2021
    Publication date: August 31, 2023
    Applicant: TAKARA BELMONT CORPORATION
    Inventors: Yuta NAKAO, Hiroyuki TERAYAMA
  • Patent number: 11667952
    Abstract: Provided are methods of producing product nucleic acids involving the use of oligonucleotides that are modified by the application of a stimulus. Aspects of such methods may include producing product nucleic acids using de-activatable oligonucleotides that are deactivated by a de-activating stimulus, as well as methods that may include producing product nucleic acids using activatable oligonucleotides that are activated by an activating stimulus and de-activatable oligonucleotides that are deactivated by a de-activating stimulus. Also provided are kits, compositions and devices that include de-activatable oligonucleotides or activatable and de-activatable oligonucleotides, e.g., for use in performing the methods as described herein.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: June 6, 2023
    Assignee: Takara Bio USA, Inc.
    Inventor: Kazuo Tori
  • Patent number: 11661628
    Abstract: The present invention regards a variety of methods and compositions for whole genome amplification and whole transcriptome amplification. In a particular aspect of the present invention, there is a method of amplifying a genome comprising a library generation step followed by a library amplification step. In specific embodiments, the library generating step utilizes specific primer mixtures and a DNA polymerase, wherein the specific primer mixtures are designed to eliminate ability to self-hybridize and/or hybridize to other primers within a mixture but efficiently and frequently prime nucleic acid templates.
    Type: Grant
    Filed: August 10, 2017
    Date of Patent: May 30, 2023
    Assignee: Takara Bio USA, Inc.
    Inventors: Emmanuel Kamberov, Tong Sun, Eric Bruening, Jonathon H. Pinter, Irina Sleptsova, Takao Kurihara, Vladimir L. Makarov
  • Publication number: 20230160023
    Abstract: Provided is a method for detecting an FNA virus in a biological sample, the method comprising: (1) a step for preparing a sample solution containing a biological sample, a protease, a nucleic acid that does not become a target of nucleic acid amplification, and at least one additive selected from the group consisting of chaotropic reagents and surfactants; (2) a step for preparing a nucleic acid amplification reaction solution containing the sample solution prepared in step (1) and containing a polypeptide having reverse transcriptase activity and DMA polymerase activity or a polypeptide having reverse transcription activity and a polypeptide having DNA polymerase activity; and (3) a step for amplifying a nucleic acid of the RNA virus in the reaction solution prepared in step (2).
    Type: Application
    Filed: April 28, 2021
    Publication date: May 25, 2023
    Applicant: TAKARA BIO INC.
    Inventors: Takashi UEMORI, Takehiro SAGARA, Miwa AKITOMO, Kensuke SAITO
  • Patent number: 11643681
    Abstract: Apparatus, systems, chips, and methods of performing a large number of simultaneous chemical reactions are provided herein. The chips of the invention comprise addressable units that can be addressed according to the temperature of the reaction to be run. The subject apparatus, systems, and chips are particularly suited for performing polymerase chain reactions on thousands of nucleic acid sequences, up to and including sequences of an entire genuine of an organism of interest.
    Type: Grant
    Filed: March 9, 2018
    Date of Patent: May 9, 2023
    Assignee: Takara Bio USA, Inc.
    Inventors: Victor Joseph, Amjad Huda, Alnoor Shivji
  • Patent number: 11643635
    Abstract: Protein enriched micro-vesicles and methods of making and using the same are provided. Aspects of the methods include maintaining a cell having a membrane-associated protein comprising a first dimerization domain and a target protein having a second dimerization domain under conditions sufficient to produce a micro-vesicle from the cell, wherein the micro-vesicle includes the target protein. Also provided are cells, reagents and kits that find use in making the micro-vesicles, as well as methods of using the micro-vesicles, e.g., in research and therapeutic applications.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: May 9, 2023
    Assignee: Takara Bio USA, Inc.
    Inventors: Michael Haugwitz, Thomas Patrick Quinn, Andrew Alan Farmer, Montserrat Morell Fernández
  • Publication number: 20230133071
    Abstract: The present invention provides a GG-specific mismatch endonuclease variant, a TT-specific mismatch endonuclease variant, and a GT/TG-specific mismatch endonuclease variant. The present invention also provides a mismatch specific cleaving reaction using said variant, a method for removing errors in a nucleic acid amplification reaction using a mismatch nuclease, a method for suppressing amplification of a nucleic acid having a specific base sequence during a nucleic acid amplification reaction, and a method for detecting a nucleic acid having a single base polymorphic mutation using said suppression method.
    Type: Application
    Filed: March 18, 2021
    Publication date: May 4, 2023
    Applicants: TAKARA BIO INC., EDUCATIONAL CORPORATION KANSAI BUNRI SOUGOUGAKUEN, KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
    Inventors: Hiroyuki MATSUMOTO, Takashi UEMORI, Tsuyoshi SHIRAI, Yoshizumi ISHINO, Sonoko ISHINO
  • Patent number: 11602477
    Abstract: An instrument hose support device includes a rod that supports an instrument hose at a position higher than an instrument that is held by a holder, a pulley support portion that is supported by a distal end of the rod, a pulley that is supported by the pulley support portion and over which the instrument hose is looped. The distal end has a groove in which a taper is formed. A first member of the pulley support portion has a shaft protrusion, and a gap is formed between the shaft protrusion and the groove. The gap serves as the range of motion of the pulley support portion, and the pulley support portion follows the movement of the instrument hose and, relative to the rod, swings freely toward the front and the back and toward the sides and rotates freely with a movable axis (X) as an axis.
    Type: Grant
    Filed: November 17, 2017
    Date of Patent: March 14, 2023
    Assignee: Takara Belmont Corporation
    Inventors: Hiroyuki Terayama, Koji Nakajima
  • Patent number: 11572580
    Abstract: The present invention pertains to: an oligonucleotide preservation method; and a kit comprising an oligonucleotide. The present invention provides a method for stably preserving an oligonucleotide-containing solution by adding a nucleic acid-binding protein to said oligonucleotide-containing solution in advance.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: February 7, 2023
    Assignee: TAKARA BIO INC.
    Inventors: Miwa Akitomo, Takashi Uemori